Achievement of minimal disease activity in psoriatic arthritis according to the time of administration of synthetic disease-modifying antirheumatic drugs, a comparative analysis of...

av T. V. Korotaeva, E. Yu. Loginova, E. E. Gubar, Yu. L. Korsakova, M. V. Sedunova, I. N. Pristavsky, I. N. Kushnir, I. F. Umnova, S. S. Kudishina
Publicerad 2021-02-01

Influence of the duration of psoriatic arthritis on the achievement of remission and minimal disease activity during therapy with genetically engineered biologic drugs. Data from t...

av E. Yu. Loginova, T. V. Korotaeva, E. E. Gubar, Yu. L. Korsakova, M. V. Sedunova, I. N. Pristavskiy, I. N. Kushnir, I. F. Umnova, S. S. Kudishina, E. L. Nasonov
Publicerad 2021-01-01

The clinical status and working capacity in patients included in the All-Russian Psoriatic Arthritis Registry

av E. Yu. Loginova, T. V. Korotaeva, Yu. L. Korsakova, E. E. Gubar, P. O. Tremaskina, E. A. Vasilenko, I. N. Kushnir, I. M. Patkikeeva, S. S. Kudishina, P. A. Shesternya, A. V. Petrov, N. A. Kuznetsova, E. L. Nasonov
Publicerad 2020-09-01

OPTIMIZING THE DIAGNOSIS, A MONITORING AND TREATMENT SYSTEM FOR PSORIATIC ARTHRITIS IN REAL PRACTICE: GENERAL PRINCIPLES FOR ORGANIZING AN ALL-RUSSIAN REGISTER OF PATIENTS WITH PSO...

av T. V. Korotaeva, Yu. L. Korsakova, E. Yu. Loginova, E. E. Gubar, A. D. Koltakova, E. E. Medved, S. S. Kudishina, A. V. Petrov, M. V. Sedunova, I. N. Pristavsky, E. A. Vasilenko, I. N. Bondareva, I. F. Umnova, P. A. Shesternya, E. L. Nasonov
Publicerad 2019-09-01